Diabetes Program | Research and Innovation

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Induced pluripotent stem (IPS) celssAs part of the effort to understand the development of genetic diseases, Boston Children’s has created induced pluripotent stem (iPS) cells, which are cells taken from patients and reprogrammed to look and function like embryonic stem cells. Scientists use these iPS cells to model the genetic diseases of the patients from whom they were taken, including Type I diabetes patients.


Boston Children’s is so much more than a hospital—it’s a community of researchers, clinicians, administrators, support staff, innovators, teachers, patients and families, all working together to make the impossible possible. ”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital
300 Longwood Avenue, Boston, MA 02115
For Patients: 617-355-6000
For Referring Providers: 844-BCH-PEDS | 844-224-7337

Close